|
|
|
News for Food and Drug Administration (FDA)News > FDAListings 251 - 260 of 441:
Mylan Announces Final FDA Approval For Fluoxetine Capsules USP, 40 Mg
Mylan Laboratories announced that Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its supp...
Perrigo Receives FDA Approval To Market Coated Fruit Nicotine Gum
The Perrigo Company announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market over-the-counter coated nicotin...
Rexahn Pharmaceuticals Receives FDA Approval to Initiate a Phase II Trial for Archexin in Patients with Renal Cell Carcinoma
Rexahn Pharmaceuticals, a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for cancer...
GE Healthcare Receives FDA Clearance For CARESCAPE Patient Data Module For Mobile Patient Monitoring
GE Healthcare announced recently U.S. Food and Drug Administration (FDA) clearance for its CARESCAPE Patient Data Module for mobile patient monitoring...
Novagali Pharma Receives US FDA Orphan Drug Designation For Vekacia For The Treatment Of Vernal Keratoconjunctivitis
Novagali Pharma, an emerging ophthalmic pharmaceutical company, announced orphan drug designation granted by the U.S. Food and Drug Administration (FD...
FDA Approves Lybrel, The First Continuous Use Drug Product for Prevention of Pregnancy
The Food and Drug Administration (FDA) approved Lybrel, the first continuous use drug product for prevention of pregnancy.The new contraceptive, Lybre...
FDA Requests Boxed Warning for Contrast Agents Used to Improve MRI Images
The U.S. Food and Drug Administration (FDA) has asked manufacturers to include a new boxed warning on the product labeling of all gadolinium-based con...
FDA Takes Action to Stop Marketing of Unapproved Timed-Release Guaifenesin Drug Products
The U.S. Food and Drug Administration (FDA) announced its intention to take action against companies that market unapproved drug products in timed-rel...
FDA Approves First New Oral Treatment for Bacterial Vaginosis
Mission Pharmacal announced that the U.S. Food and Drug Administration (FDA) approved Tindamax (tinidazole) for the treatment of bacterial vaginosis (...
FDA Approves Wyeth's Oral Contraceptive Lybrel
FDA has approved Wyeth's oral contraceptive Lybrel, which is designed to eliminate monthly menstrual periods, the Los Angeles Times reports. Lybrel, w... |
|
|
Privacy Policy | Terms & Conditions | Support | Directory Links | Contact Us | Site Map | Home Copyright © 2007-2008 ComplianceHome.com. A SUPREMUS GROUP venture. All rights reserved. |